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Abstract
Background: The aim of this study was to determine the prevalence of Dal, and DEA 1, 4, 7 blood types, in a
population of canine blood donors from Italy and Spain. Three hundred and twenty blood donor dogs receiving an
annual health evaluation were included in the study. DEA 1 blood type was determined using an
immunochromatographic strip technique while Dal, DEA 4 and 7 blood types were determined with polyclonal
antisera using agglutination on gel columns.
Results: Out of 320 dogs blood typed 7 (2 Cane Corso and 5 Doberman Pinschers) (2.2%) were Dal negative; 137
(42.8%) were positive for DEA 1; 320 (100%) were positive for DEA 4 and 43 (13.4%) were positive for DEA 7.
Conclusion: This study showed a similar prevalence of DEA 1, 7 and 4 to that reported in previous studies in the
same, and in different, geographic areas, and provides new data on the prevalence of the Dal blood group in Italy
and Spain. There was no significant difference (P = 0.8409) between prevalence of Dal negative blood types found
in our population (2.2%) and the prevalence reported in a canine blood donor population from the USA (2.5%). Our
study identified Dal negative dogs in a previously tested breed i.e. Doberman Pinschers, but also the Cane Corso
breed was found to have Dal negative dogs.
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Background
Blood groups are species-specific genetic markers on the
surface of erythrocyte cell membranes which are defined
according to antigenic recognition [1]. In dogs, there are
seven internationally recognized blood groups in the
Dog Erythrocyte Antigen (DEA) classification (DEA 1, 3,
4, 5, 6, 7, 8) [2] and, since these blood groups are inde-
pendent, more than one blood group can be co-
expressed on the surface of canine red blood cells [3, 4].
The DEA 1 is the most studied antigen. Worldwide
prevalence of DEA 1 positive dogs has been estimated to
be around 50–65% [5–9]. DEA 1 blood type is the most
clinically important blood group in terms of transfusion
reactions. Following the first transfusion with DEA 1
positive RBCs, DEA 1 negative dogs produce anti-DEA 1
antibodies and are at risk of potentially fatal, acute
hemolytic reactions when a second DEA 1 mismatched
transfusion is administered [10].
DEA 4 is a high frequency antigen in the canine popula-
tion [9, 11–13], but there has been only one documented
occurrence of a DEA 4 positive transfusion to a DEA 4
negative dog which had previously been sensitized by a
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DEA 4 unit of blood leading to a severe hemolytic transfu-
sion reaction [14].
The prevalence of DEA 7 positive blood type varies be-
tween 5 and 82% depending on geographical
localization, breed investigated and there is also probably
an effect of the different methodologies used in the stud-
ies [11, 15–18]. An additional blood type, named Dal,
was first recognized more than a decade ago. The Dal
antigen was initially described in an anemic Dal negative
Dalmatian accidentally sensitized by a first transfusion
from a Dal positive canine blood donor [4]. A high per-
centage of Dal negative Dalmatians and Doberman
pinchers have been reported in North America, whereas
there is a high prevalence of Dal positive individuals in
blood donor dogs from other breeds [19]. Dal negative
blood donors might be difficult to find and, since Dal
positive donors are common, Dal negative dogs are at
increased risk of being sensitized by a first blood transfu-
sion and face a high risk of acute hemolytic transfusion
reactions following subsequent blood transfusion [20], as
previous studies have shown that dogs have no naturally
occurring anti-Dal antibodies [4, 16]. Euler et al. (2016),
investigated the prevalence of two new blood groups,
Kai 1 and Kai 2, and found that most dogs in North
America were Kai1+/Kai 2-. No relationship was found
between the Kai 1 and 2 and the DEA or Dal blood
group systems. Furthermore a study [21] in Korea
showed that dogs had no naturally occurring anti-Kai 1
and Kai 2 alloantibodies. A further survey in Germany
found similar proportions of positive and negative of
DEA 1,4, Kai 1 and 2 and Dal blood types to those in
North America [22].
To the author’s knowledge, the prevalence of the Dal
blood group has been investigated in only one blood
donor dog population in USA, and there is limited pub-
lished information on the prevalence of DEA 4 and 7,
probably due to the limited availability of blood typing
reagents. The aim of this study was to determine the
prevalence of DEA 1, 4 and 7 and Dal blood group anti-
gens in a population of blood donor dogs from Italy and
Spain.
Methods
Blood samples
In this study, surplus blood samples in ethylene-diamine
tetra acetic acid (EDTA) from 320 clinically healthy ca-
nine blood donors from the Mediterranean area of Eur-
ope were used. No dog had a previous history of blood
transfusion. Canine blood donors (> 23 kg, 2–8 years
old) were recruited from 3 University blood banks from
northern (University of Milan, Lombardy), central (Uni-
versity of Pisa, Tuscany) and southern (University of
Messina, Sicily) Italy and from a private blood bank
(Centro de Transfusion Veterinario, CTV) in Madrid,
Spain. The blood was collected from canine blood do-
nors as part of routine annual health monitoring, and
owners gave consent for the use of excess blood after
routine testing in further studies. The study was con-
ducted in accordance with European legislation (2010/
63/EU) and was approved by the local bioethical com-
mittee of the University of Milan (EC26/2018). Data on
gender, age and origin (where dogs lived and blood was
collected, i.e. Northern, Central, Southern Italy or Spain)
were collected from each dog sampled. Blood typing was
performed at the Veterinary Transfusion Research La-
boratory (Laboratorio di Ricerca di Medicina Emotrasfu-
sionale Veterinaria, REVLab), University of Milan,
Milan, Italy. After blood collection the samples were im-
mediately sent to the laboratory. They were kept refrig-
erated and blood type was assessed within 7 days of
blood collection [23]. To avoid agglutination interfer-
ence, prior to performing blood typing, all samples were
macroscopically evaluated for autoagglutination as fol-
lows: a drop of whole blood and saline was placed on a
slide. The slide was rotated transaxially and the presence
of agglutination was evaluated within 2 min. Microscopic
autoagglutination was evaluated by microscopic evalu-
ation (× 40). If macro or micro agglutination was
present, the samples were excluded from the study.
Blood typing
The polyclonal anti-DEA 4 and 7 antisera used in this
study were purchased from ABRI (Animal Blood Re-
sources International, USA) and imported to the Univer-
sity of Milan with the authorization of the Italian Health
Minister (protocol authorization No. 0024135–23/09/
2015- DGSAF-COD_UO-P). Dal blood typing was per-
formed using polyclonal anti-Dal antibody obtained from
Dal sensitized research Beagles from the University of
Montreal, used undiluted as previous described [17].
In all samples blood typing was performed as de-
scribed below.
DEA 1 blood type was determined using an immuno-
chromatographic strip technique using monoclonal anti-
body (Lab Test DEA 1, Alvedia, Limonest, France)
following the manufacturer’s guidelines.
DEA 4 and DEA 7 blood types, and Dal blood type,
were determined with polyclonal antiserum using agglu-
tination on gel columns (ID-CARD NaCl enzyme test
and cold agglutinins, DiaMed GmgH, Cressier FR,
Switzerland) as previously described [16, 17].
For all three blood types, DEA 4, DEA 7 and Dal, all
blood samples mixed with polyclonal antiserum, were
centrifuged in a dedicated gel column card centrifuge
(ID-Centrifuge 24 S, DiaMed GmbH, Cressier FR,
Switzerland) at 80×g for 10 min. The gel column cards
were evaluated for the presence and strength of agglutin-
ation. The gel cards were visually interpreted and
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agglutination reactions graded from 0 to 4 + in accord-
ance with the manufacturer’s instructions as follows
[24]: 0, negative, all RBCs were at the bottom of the col-
umn; 1+, very few RBC agglutinates dispersed in the
lower part of the gel, with most RBCs at the bottom of
the tube; 2+, all RBCs were agglutinated and dispersed
in the gel; 3+, some RBC agglutinates were dispersed in
the upper part of the gel and most of the RBCs formed a
red line on the surface of the gel; and 4+, all RBCs
formed a red line on top of the gel. Results were inter-
preted as negative if no, or just 1+, agglutination was
present, whereas ≥2+ agglutination reactions were con-
sidered positive [16, 19]. Results were considered valid if
the control column containing only the RBC suspension
and saline, was negative with all RBCs on the bottom of
the column.
Prevalence and statistics of dal positive dogs
Prevalence of the DEAs and Dal positive blood types
were calculated as the proportion of samples testing
positive for the different DEA and Dal blood types. The
Pearson’s chi-square test was used for statistical com-
parison of Dal prevalence in our dog population with
the prevalence of Dal in the blood donor population pre-
viously typed for Dal. Statistical software (Medcalc Soft-
ware, version 16.4.3) was used for all analyses and
statistical significance was set at P < 0.05.
Results
Of the 320 blood donor dogs, 201 were female and 119
male; 50 were Spanish Greyhounds (from Madrid,
Spain), 49 were Cane Corsos (35 from Messina, southern
Italy and 14 from Milan, northern Italy), 46 were Dober-
man Pinschers (39 from Milan, northern Italy and 7
from Pisa, central Italy), 39 were Golden Retrievers
(from Milan northern Italy), 25 were Boxers (from Pisa,
central Italy), 22 were Argentine Dogos (from Milan,
northern Italy), 19 were Siberian Huskies (from Milan,
northern Italy), 18 were Samoyeds (from Milan, north-
ern Italy), 17 were Bernese Mountain dogs and 35 were
other breeds (13 mongrels, 5 Rhodesian Ridgebacks, 6
Irish Wolfhounds, 5 Italian Spinone, 4 German Shep-
herds and 2 Akita Inus, (all from northern Italy). No
samples showed autoagglutination.
Of the 320 dogs blood typed for DEA 1, 137/320
(42.8%) were positive and 183/320 (57.2%) were negative.
All 320/320 (100%) blood samples tested were positive
for DEA 4, 43/320 (13.4%) were positive for DEA 7 and
277/320 (86.6%) were negative. Of the 320 dogs blood
typed for Dal, 7/320 (2.2%) were Dal negative, 2 Cane
Corso (one from northern and one from southern Italy)
and 5 Doberman Pinschers (all from central Italy). Total
prevalence of DEA 1, DEA 7 positive and Dal positive
and negative dogs in breeds represented by > 10 individ-
uals is reported in Table 1.
All seven Dal negative blood donor dogs were also nega-
tive for DEA 1 and 7 and positive for DEA 4. There was
no significant difference (P = 0.84091) between the preva-
lence of Dal negative blood types in our population of
blood donor dogs (7/320; 2.2%) and the blood donor dog
population previously analyzed in USA (6/245; 2.4%) [19].
The percentage of Dal negative Dobermann Pinschers
typed in our study (10.9%) was significantly lower (P =
0.00235) than those found in the USA (42.4%) [19].
Discussion
Blood typing prior to canine blood transfusions mini-
mizes the risk of transfusion reaction due to blood type
incompatibility. Information on the prevalence of differ-
ent blood types in various breeds aids the selection of
blood donors for inclusion in a blood donor program
[2]. This study showed a similar prevalence of DEA 1, 7
and 4 to that reported in previous studies in the same,
and in different, geographic areas [16, 17, 19, 22].
Canine blood groups have been reported to vary geo-
graphically and between breeds [11–13], and the recog-
nition of new canine blood groups, such as Dal and Kai
1 and Kai 2 antigens, demands further epidemiological
studies to provide new information about the prevalence
of these blood groups [4, 25]. In the USA, Dalmatians
and Doberman Pinschers were identified as breeds with
a high prevalence of Dal negative dogs [19]. However,
Dal negative Beagles, Shih Tzus and Lhasa Apsos were
also identified [19].
In the present study, using gel column technology and
polyclonal anti-Dal antibodies, seven Dal negative blood
donor dogs were identified from Italy and Spain with no
significant difference between this population and the
prevalence of Dal negative blood donor dogs in the
population previously analyzed in USA [19].
The scarcity of Dal negative dogs among blood donors
raises a concern that Dal negative dogs receiving an in-
compatible transfusion risk being sensitized. The Dal
blood group is not, as previously hypothesized, a high-
frequency antigen such as DEA 4, but seems to be miss-
ing in some dogs within certain breeds. There are also
some breeds where > 10% of the dogs are Dal negative
[19]. The identification of breeds with a high prevalence
of Dal negative subjects would be advantageous to im-
prove guidelines for blood donor dogs recruitment, until
a commercial test is developed for Dal blood typing dur-
ing routine clinical testing.
The Dal group seems to have an autosomal dominant
mode of inheritance similar to that previously identified
in other canine blood groups [19]. Furthermore, Dal
positive parents usually produce only Dal positive
Proverbio et al. BMC Veterinary Research          (2020) 16:126 Page 3 of 5
offspring, and Dal negative offspring are uncommon if
both parents are Dal positive.
Although, only a small number of Doberman
Pinschers were typed (n = 46) in our study compared to
the study in the USA (n = 432), we confirmed a high per-
centage of Dal negative dogs in this breed, although
numbers were significantly lower than those found in
the study from the USA [19].
The Dal blood group in Doberman Pinschers may
have clinical importance, given the high prevalence of
von Willebrand disease (vWD) in this breed [26]. Af-
fected dogs have a high risk of bleeding and may need
multiple transfusions [27], increasing their risk of being
sensitized to the Dal antigen, developing Dal alloanti-
bodies and experiencing a transfusion reaction.
The risk of an acute transfusion reaction linked to the Dal
group, would most likely be confined to dogs receiving mul-
tiple transfusions as previous studies have shown that dogs
have no naturally occurring anti-Dal antibodies [4, 16].
As there is no relationship between the DEA blood
types tested and Dal positivity [19, 22], and because Dal
testing is not currently routinely available, the only way
to evaluate transfusion compatibility for the Dal group is
by cross-matching. Cross-matching must always be car-
ried out in dogs receiving further transfusions 4 days
after the first. Our study also identified Dal negative
dogs in the Cane Corso breed. This finding is of particu-
lar interest because the Cane Corso dog is an ancient
Italian large breed dog that makes a very good blood
donor for a number of reasons: large size (> 25 kg body-
weight), good temperament, easy and readily accessible
jugular veins and significant higher DEA 1 and DEA 7
negative prevalence than most of the canine populations
previously surveyed [7, 9, 11]. Our study also confirms
the high prevalence of DEA 1 and DEA 7 negative sub-
jects in this breed.
In this study, we typed only a small number of blood
donor dogs, and further studies are required to estimate
the real prevalence of Dal negative dogs in Doberman
Pinschers, Cane Corsos and other blood donor breeds in
Europe. Furthermore, the findings in the Cane Corso
breed, which is classified in the Molossoid group, might
prompt testing of other Molossoid breeds for identifica-
tion of those with a higher prevalence of Dal negative in-
dividuals. As relevant antisera are not commercially
available, it was not possible to assay DEA 3, 5 and Kai 1
and Kai 2 blood types [21, 22, 25], so the relationship of
these with the Dal blood type could not be investigated.
Conclusions
This study showed a similar prevalence of DEA 1, 7 and
4 to that reported in previous studies in the same, and
different, geographic areas, and provides new data on
the prevalence of the Dal blood group, in Italy and
Spain. This study identified Dal negative blood donor
dogs in a previously tested breed i.e. Doberman
Pinschers, but the Cane Corso breed was also found to
contain Dal negative dogs.
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